Commenting on the development, Cliantha Research Executive Director Vijay Patel said: "Karmic gives us an opportunity to expand in the clinical data management, pharmaceutical analytics and medical marketing business."
Cliantha Research shall immediately be able to execute and port all its trials on to kTrials eClinical Suite, he added.
"Cliantha brings in strong clinical, bio-analytical and diagnostics capabilities that lend huge synergy to our existing clinical business, apart from the strategic flexibility and financial stability of a well-established partner," Karmic Lifesciences CEO Nidhi Saxena said.